IGM Biosciences' GAAP loss for 6M 2021 was $70.358 million, up 93% from $36.463 million in the previous year.
IGM Biosciences' GAAP loss for 6M 2021 was $70.358 million, up 93% from $36.463 million in the previous year.
Financial results
IGM Biosciences' GAAP loss for 6M 2021 was $70.358 million, up 93% from $36.463 million in the previous year. Source: 
igmbio.gcs-web.com
igmbio.gcs-web.com News feed
English (US) 